{"2CV.F": {"short_name": "CONVATEC GROUP WI LS -,10", "long_name": "Convatec Group Plc", "summary": "ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "FRA", "market": "dr_market", "country": "United Kingdom", "city": "Reading"}, "2CVU.F": {"short_name": "CONVATEC GRP UNSP.ADR /4", "long_name": "Convatec Group Plc", "summary": "ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "FRA", "market": "dr_market", "country": "United Kingdom", "city": "Reading"}, "AQA.F": {"short_name": "ADVANCED MED.SO.GRP LS-05", "long_name": "Advanced Medical Solutions Group plc", "summary": "Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand; sutures and collagen based products for the surgical and dental markets under the RESORBA; collagens; and laparoscopic device which reduces surgical complications under the LiquiBand Fix8 brands. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal. It also sells its products under the Seal-G and Biomatlante brand names, such as Moldable Bone Graft Substitute, a biphasic calcium phosphate synthetic bone graft substitute that includes Syringes, Inserts, and In'Oss; EZ Cure, a collagen membranes; and Osteotwin, a Biocompatible Interference Resorbable Screw. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "FRA", "market": "dr_market", "country": "United Kingdom", "city": "Winsford"}, "CNVVY": {"short_name": "CONVATEC GROUP PLC", "long_name": "Convatec Group Plc", "summary": "ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "PNK", "market": "us_market", "country": "United Kingdom", "city": "Reading"}, "CTEC.L": {"short_name": "CONVATEC GROUP PLC ORD 10P", "long_name": "Convatec Group Plc", "summary": "ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Reading"}, "MDVI.TA": {"short_name": "MEDIVIE THERP-M", "long_name": "Medivie Therapeutic Ltd", "summary": "Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the child's gingival structure and teeth. Its product has applications in the areas of birth, migraines, chronic pains, and improving concentration and cognitive activity. The company markets and distributes its products through a network of distributors, as well as online in the Asia, Latin America, the United States, Europe, and Canada. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom.", "currency": "ILA", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "TLV", "market": "il_market", "country": "United Kingdom", "city": "Hemel Hempstead"}, "ODX.L": {"short_name": "OMEGA DIAGNOSTICS GROUP PLC ORD", "long_name": "Omega Diagnostics Group PLC", "summary": "Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries, Africa, and the Middle East. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. This segment's product includes 69 CE-marked allergens. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides CNS laboratory services that offer clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Infectious Diseases and Other segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment's products include VISITECT CD4, an in-vitro diagnostic test, which is used in the management of patients with pre-diagnosed HIV infection, as well as develops and manufactures COVID-19 antibody and antigen tests. The company offers its products to hospitals, clinics, and laboratories through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Alva"}, "RVKA.F": {"short_name": "OMEGA DIAGNOST.GR. LS-,04", "long_name": "Omega Diagnostics Group PLC", "summary": "Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries, Africa, and the Middle East. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. This segment's product includes 69 CE-marked allergens. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides CNS laboratory services that offer clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Infectious Diseases and Other segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment's products include VISITECT CD4, an in-vitro diagnostic test, which is used in the management of patients with pre-diagnosed HIV infection, as well as develops and manufactures COVID-19 antibody and antigen tests. The company offers its products to hospitals, clinics, and laboratories through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "FRA", "market": "dr_market", "country": "United Kingdom", "city": "Alva"}, "SPEC.L": {"short_name": "INSPECS GROUP PLC ORD 1P", "long_name": "Inspecs Group plc", "summary": "Inspecs Group PLC designs, produces, sells, markets, and distributes fashion eyewear and original equipment manufacturer products worldwide. It provides a range of prescription optical eyewear under the various brand names and private labels; sunglasses; and safety products under the Caterpillar brand. Inspecs Group PLC offers its products directly to retailers, specialist distributors, and brand partners. The company also sells its products through a network of approximately 30,000 points of sale in 80 countries worldwide. Inspecs Group PLC was founded in 1988 and is headquartered in Bath, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Bath"}, "TSTL.L": {"short_name": "TRISTEL PLC ORD 1P", "long_name": "Tristel plc", "summary": "Tristel plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products under the Tristel brand; surface cleaning and disinfection products used in areas, such as hospitals, rescue vehicles, care homes, hospices, dentists, and GP surgeries under the Cache brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand. Tristel plc was founded in 1993 and is based in Snailwell, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Snailwell"}}